Overview

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The T-001 study is a placebo-controlled investigation of the effects of injectable testosterone replacement therapy on prostate tissues of aging men with low testosterone levels.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Leonard S. Marks, M.D.
Urological Sciences Research Foundation
Collaborators:
Solvay Pharmaceuticals
Watson Pharmaceuticals
Treatments:
Androgens
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate